Cannabis for Diabetes Mellitus

Studies and Information on Cannabis for Diabetes Mellitus

Diabetes is a disease related to the pancreas, a relatively small gland located behind the stomach and in front of the spine that opens into the duodenum (neck of the small intestine). Of all the glands in the endocrine system, the pancreas, along with the adrenals, sits directly in the body’s center. The pancreas produces hormones such as insulin and glucagon as well as digestive enzymes that break down food into basic sugar molecules usable as food/energy by each cell of the human body.

Traditionally, orthodox medicine categorizes diabetes into three kinds: Type I, Type II, and gestational diabetes. Type I diabetes was once called juvenile diabetes because it occurred mostly in children or adolescents. In Type I, the pancreas stops producing the hormone insulin. Without insulin the body cannot use the food life depends on, cellular sugar. Treatment in the orthodox paradigm consists of daily insulin injections, normally administered by the patients themselves.

Type II diabetes, or adult-onset diabetes, is the most common form of the disease. In Type II the pancreas does not produce enough insulin, or the body’s cells are insensitive to the presence of insulin and ignore it. This prevents the body from converting sugar into energy. Early Type II usually does not require the use of insulin; modern medical practitioners generally prescribe oral pharmaceuticals instead.

Ratings for Cannabis and Diabetes Mellitus

Rated 2.6 / 5 (How Ratings Work)


Possible to probable range of efficacy of cannabis for treatment of diabetes mellitus.
Based on 23 Studies from 2001 - 2016

Studies on Cannabis and Diabetes Mellitus


Study Name, Description & Year


Rating



Efficacy And Safety Of Cannabidiol And Tetrahydrocannabivarin On Glycemic And Lipid Parameters In Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
A randomized, double-blind, placebo-controlled study, 62 subjects with noninsulin-treated type 2 diabetes were randomized to five treatment arms: CBD (100 mg twice daily), THCV (5 mg twice daily), 1:1 ratio of CBD and THCV (5 mg/5 mg, twice daily), 20:1 r — 2016

5




Efficacy Of Inhaled Cannabis On Painful Diabetic Neuropathy.
A randomized, double-blinded, placebo controlled crossover study was conducted in 16 patients with painful diabetic peripheral neuropathy — 2015

5





The Impact Of Marijuana Use On Glucose, Insulin, And Insulin Resistance Among US Adults
Survey of 4657 adult men and women. 579 were current marijuana users and 1975 were past users. — 2013

3